Stroke in HIV infection and AIDS
HIV/AIDS appears to increase the risk of both ischemic and hemorrhagic stroke. This increased risk is most apparent in the young HIV-infected population in which other risk factors for stroke are seldom evident. Mechanisms underlying the increased risk include opportunistic infectious meningitides a...
Gespeichert in:
| Veröffentlicht in: | Expert review of cardiovascular therapy 2009-10, Vol.7 (10), p.1263-1271 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1271 |
|---|---|
| container_issue | 10 |
| container_start_page | 1263 |
| container_title | Expert review of cardiovascular therapy |
| container_volume | 7 |
| creator | Dobbs, Michael R Berger, Joseph R |
| description | HIV/AIDS appears to increase the risk of both ischemic and hemorrhagic stroke. This increased risk is most apparent in the young HIV-infected population in which other risk factors for stroke are seldom evident. Mechanisms underlying the increased risk include opportunistic infectious meningitides and vasculitides, primary HIV vasculopathy, altered coagulation and cardioembolic events, although the cause may be multifactorial or remain cryptic. With better control of HIV via effective, highly active antiretroviral therapy, the role of many of these risks has been mitigated, only to be supplanted by an aging population with more conventional atherosclerotic risk factors magnified by the hyperlipidemia attending the use of protease inhibitors. Selecting the appropriate therapy for treating stroke in the HIV-infected patient is dependent on diagnostic rigor in identifying its underlying etiology. |
| doi_str_mv | 10.1586/erc.09.72 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_21275723</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A239788467</galeid><sourcerecordid>A239788467</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-c3420fcc84748c74f8c8abe2372025e5dacd35991b0af6e32e3d4adee86bf1cd3</originalsourceid><addsrcrecordid>eNptkEtLAzEQgIMoWKsH_8HiQfCwazbJbpJj8dVCwUPVa0izE7t1d1OTLdJ_b8p68EUgMyTfN8wMQuc5zvJClNfgTYZlxskBGuWcsVRQxg5jzjhPJebkGJ2EsMaYMlnQEUoWvXdvkNRdMp29xGDB9LXrEt1VyWR2uzhFR1Y3Ac6-4hg939893UzT-ePD7GYyTw0tSR9vRrA1RjDOhOHMCiP0EgjlBJMCikqbihZS5kusbQmUAK2YrgBEubR5_Bujy6Huxrv3LYRetXUw0DS6A7cNiuSEF5zQCF78Atdu67vYm8plUVJZch6hbIBedQMqTuV6r008FbS1cR3YOr5PCJVcCFbuhatBMN6F4MGqja9b7Xcqx2q_WRU3q7BUsYUxYgO7r-tb_eF8U6le7xrnrdedqYOi_2n0h7YC3fQroz18m-CP9QkqlY0U</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195639677</pqid></control><display><type>article</type><title>Stroke in HIV infection and AIDS</title><source>Alma/SFX Local Collection</source><creator>Dobbs, Michael R ; Berger, Joseph R</creator><creatorcontrib>Dobbs, Michael R ; Berger, Joseph R</creatorcontrib><description>HIV/AIDS appears to increase the risk of both ischemic and hemorrhagic stroke. This increased risk is most apparent in the young HIV-infected population in which other risk factors for stroke are seldom evident. Mechanisms underlying the increased risk include opportunistic infectious meningitides and vasculitides, primary HIV vasculopathy, altered coagulation and cardioembolic events, although the cause may be multifactorial or remain cryptic. With better control of HIV via effective, highly active antiretroviral therapy, the role of many of these risks has been mitigated, only to be supplanted by an aging population with more conventional atherosclerotic risk factors magnified by the hyperlipidemia attending the use of protease inhibitors. Selecting the appropriate therapy for treating stroke in the HIV-infected patient is dependent on diagnostic rigor in identifying its underlying etiology.</description><identifier>ISSN: 1477-9072</identifier><identifier>EISSN: 1744-8344</identifier><identifier>DOI: 10.1586/erc.09.72</identifier><language>eng</language><publisher>London: Informa Healthcare</publisher><subject>AIDS ; AIDS (Disease) ; Control ; Development and progression ; epidemiology ; Highly active antiretroviral therapy ; HIV ; HIV (Viruses) ; HIV patients ; Human immunodeficiency virus ; intracerebral hemorrhage ; Protease inhibitors ; Proteases ; Risk factors ; stroke ; vasculopathy</subject><ispartof>Expert review of cardiovascular therapy, 2009-10, Vol.7 (10), p.1263-1271</ispartof><rights>Expert Reviews Ltd 2009</rights><rights>COPYRIGHT 2009 Expert Reviews Ltd.</rights><rights>2009 Expert Reviews Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-c3420fcc84748c74f8c8abe2372025e5dacd35991b0af6e32e3d4adee86bf1cd3</citedby><cites>FETCH-LOGICAL-c362t-c3420fcc84748c74f8c8abe2372025e5dacd35991b0af6e32e3d4adee86bf1cd3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Dobbs, Michael R</creatorcontrib><creatorcontrib>Berger, Joseph R</creatorcontrib><title>Stroke in HIV infection and AIDS</title><title>Expert review of cardiovascular therapy</title><description>HIV/AIDS appears to increase the risk of both ischemic and hemorrhagic stroke. This increased risk is most apparent in the young HIV-infected population in which other risk factors for stroke are seldom evident. Mechanisms underlying the increased risk include opportunistic infectious meningitides and vasculitides, primary HIV vasculopathy, altered coagulation and cardioembolic events, although the cause may be multifactorial or remain cryptic. With better control of HIV via effective, highly active antiretroviral therapy, the role of many of these risks has been mitigated, only to be supplanted by an aging population with more conventional atherosclerotic risk factors magnified by the hyperlipidemia attending the use of protease inhibitors. Selecting the appropriate therapy for treating stroke in the HIV-infected patient is dependent on diagnostic rigor in identifying its underlying etiology.</description><subject>AIDS</subject><subject>AIDS (Disease)</subject><subject>Control</subject><subject>Development and progression</subject><subject>epidemiology</subject><subject>Highly active antiretroviral therapy</subject><subject>HIV</subject><subject>HIV (Viruses)</subject><subject>HIV patients</subject><subject>Human immunodeficiency virus</subject><subject>intracerebral hemorrhage</subject><subject>Protease inhibitors</subject><subject>Proteases</subject><subject>Risk factors</subject><subject>stroke</subject><subject>vasculopathy</subject><issn>1477-9072</issn><issn>1744-8344</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNptkEtLAzEQgIMoWKsH_8HiQfCwazbJbpJj8dVCwUPVa0izE7t1d1OTLdJ_b8p68EUgMyTfN8wMQuc5zvJClNfgTYZlxskBGuWcsVRQxg5jzjhPJebkGJ2EsMaYMlnQEUoWvXdvkNRdMp29xGDB9LXrEt1VyWR2uzhFR1Y3Ac6-4hg939893UzT-ePD7GYyTw0tSR9vRrA1RjDOhOHMCiP0EgjlBJMCikqbihZS5kusbQmUAK2YrgBEubR5_Bujy6Huxrv3LYRetXUw0DS6A7cNiuSEF5zQCF78Atdu67vYm8plUVJZch6hbIBedQMqTuV6r008FbS1cR3YOr5PCJVcCFbuhatBMN6F4MGqja9b7Xcqx2q_WRU3q7BUsYUxYgO7r-tb_eF8U6le7xrnrdedqYOi_2n0h7YC3fQroz18m-CP9QkqlY0U</recordid><startdate>20091001</startdate><enddate>20091001</enddate><creator>Dobbs, Michael R</creator><creator>Berger, Joseph R</creator><general>Informa Healthcare</general><general>Taylor & Francis</general><general>Expert Reviews Ltd</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>20091001</creationdate><title>Stroke in HIV infection and AIDS</title><author>Dobbs, Michael R ; Berger, Joseph R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-c3420fcc84748c74f8c8abe2372025e5dacd35991b0af6e32e3d4adee86bf1cd3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>AIDS</topic><topic>AIDS (Disease)</topic><topic>Control</topic><topic>Development and progression</topic><topic>epidemiology</topic><topic>Highly active antiretroviral therapy</topic><topic>HIV</topic><topic>HIV (Viruses)</topic><topic>HIV patients</topic><topic>Human immunodeficiency virus</topic><topic>intracerebral hemorrhage</topic><topic>Protease inhibitors</topic><topic>Proteases</topic><topic>Risk factors</topic><topic>stroke</topic><topic>vasculopathy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dobbs, Michael R</creatorcontrib><creatorcontrib>Berger, Joseph R</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Expert review of cardiovascular therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dobbs, Michael R</au><au>Berger, Joseph R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Stroke in HIV infection and AIDS</atitle><jtitle>Expert review of cardiovascular therapy</jtitle><date>2009-10-01</date><risdate>2009</risdate><volume>7</volume><issue>10</issue><spage>1263</spage><epage>1271</epage><pages>1263-1271</pages><issn>1477-9072</issn><eissn>1744-8344</eissn><abstract>HIV/AIDS appears to increase the risk of both ischemic and hemorrhagic stroke. This increased risk is most apparent in the young HIV-infected population in which other risk factors for stroke are seldom evident. Mechanisms underlying the increased risk include opportunistic infectious meningitides and vasculitides, primary HIV vasculopathy, altered coagulation and cardioembolic events, although the cause may be multifactorial or remain cryptic. With better control of HIV via effective, highly active antiretroviral therapy, the role of many of these risks has been mitigated, only to be supplanted by an aging population with more conventional atherosclerotic risk factors magnified by the hyperlipidemia attending the use of protease inhibitors. Selecting the appropriate therapy for treating stroke in the HIV-infected patient is dependent on diagnostic rigor in identifying its underlying etiology.</abstract><cop>London</cop><pub>Informa Healthcare</pub><doi>10.1586/erc.09.72</doi><tpages>9</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1477-9072 |
| ispartof | Expert review of cardiovascular therapy, 2009-10, Vol.7 (10), p.1263-1271 |
| issn | 1477-9072 1744-8344 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_21275723 |
| source | Alma/SFX Local Collection |
| subjects | AIDS AIDS (Disease) Control Development and progression epidemiology Highly active antiretroviral therapy HIV HIV (Viruses) HIV patients Human immunodeficiency virus intracerebral hemorrhage Protease inhibitors Proteases Risk factors stroke vasculopathy |
| title | Stroke in HIV infection and AIDS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T08%3A25%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Stroke%20in%20HIV%20infection%20and%20AIDS&rft.jtitle=Expert%20review%20of%20cardiovascular%20therapy&rft.au=Dobbs,%20Michael%20R&rft.date=2009-10-01&rft.volume=7&rft.issue=10&rft.spage=1263&rft.epage=1271&rft.pages=1263-1271&rft.issn=1477-9072&rft.eissn=1744-8344&rft_id=info:doi/10.1586/erc.09.72&rft_dat=%3Cgale_proqu%3EA239788467%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195639677&rft_id=info:pmid/&rft_galeid=A239788467&rfr_iscdi=true |